3//SEC Filing
Lundbeckfond Invest A/S 3
Accession 0001209191-23-054275
CIK 0001907108other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 9:37 PM ET
Size
6.1 KB
Accession
0001209191-23-054275
Insider Transaction Report
Form 3
Lundbeckfond Invest A/S
10% Owner
Holdings
Series A convertible preferred stock
→ Common Stock (1,321,474 underlying)Series B convertible preferred stock
→ Common Stock (246,883 underlying)
Footnotes (2)
- [F1]Each share of Series A convertible preferred stock is convertible into Common Stock on a 1-for-10.594230 basis at any time at the Reporting Person's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. The shares have no expiration date.
- [F2]Each share of Series B convertible preferred stock is convertible into Common Stock on a 1-for-10.594230 basis at any time at the Reporting Person's election, and automatically upon the closing of the Issuer's initial public offering without payment or further consideration. Excludes shares of Common Stock issuable upon the closing of the Issuer's initial public offering pursuant to anti-dilution adjustment provisions of the Series B convertible preferred stock. The shares have no expiration date.
Documents
Issuer
Lexeo Therapeutics, Inc.
CIK 0001907108
Entity typeother
IncorporatedDenmark
Related Parties
1- filerCIK 0001591046
Filing Metadata
- Form type
- 3
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 9:37 PM ET
- Size
- 6.1 KB